U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors ...

The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab-hncq) for routine prophylaxis aimed at ...

Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing price ...

H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating ... reflecting the company’s diverse pipeline and the promising prospects in Hemophilia A and transthyretin amyloidosis programs.

The Food and Drug Administration approved Pfizer's Hympavzi to prevent or reduce bleeding episodes in patients with certain kinds of hemophilia, the pharmaceutical company said. Write to Rob Curran at ...

Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...

TEMPLE, Texas — Baylor Scott and White McLane Children's hospital unveiled a new mural this morning honoring Central Texas ...

In March 2023, the Organising Committee of the Third International Summit on Human Genome Editing published a statement ...

Founded in 2020 and headquartered in Altrincham, the United Kingdom, Centessa’s innovative pipeline includes several notable ...

Drugmakers and insurers are exploring different payment schemes for expensive, potentially curative treatments, particularly ones tied to patient response.

The Naderi Center is pleased to announce that Dr. Shervin Naderi has been named a 2024 Washingtonian Top Doctor, highlighting Dr. Naderi's expertise in rhinoplasty, aesthetic injections, and ...

TSMC is planning new factories in Europe focused on AI chips after starting construction on its first plant in Dresden, ...